Pulmatrix Stock Price on October 10, 2024
| PULM Stock | USD 6.12 0.01 0.16% |
If you're considering investing in Pulmatrix Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pulmatrix stands at 6.12, as last reported on the 23rd of November, with the highest price reaching 6.58 and the lowest price hitting 5.96 during the day. Pulmatrix is very risky given 3 months investment horizon. Pulmatrix maintains Sharpe Ratio (i.e., Efficiency) of 0.19, which implies the firm had a 0.19% return per unit of risk over the last 3 months. We were able to break down and interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 2.28% are justified by taking the suggested risk. Use Pulmatrix Semi Deviation of 3.31, coefficient of variation of 514.75, and Risk Adjusted Performance of 0.1583 to evaluate company specific risk that cannot be diversified away.
Pulmatrix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pulmatrix |
Sharpe Ratio = 0.1943
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | PULM | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.74 actual daily | 96 96% of assets are less volatile |
Expected Return
| 2.28 actual daily | 45 55% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Pulmatrix is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pulmatrix by adding it to a well-diversified portfolio.
Related Headline
Crinetics Pharmaceuticals Headline on 10th of October 2024
Crinetics Pharmaceuticals Announces October 2024 Inducement ... by globenewswire.com
SAN DIEGO, Oct. 10, 2024 -- Crinetics Pharmaceuticals, Inc. today announced that on October 10, 2024, the Compensation...
Pulmatrix Valuation on October 10, 2024
It is possible to determine the worth of Pulmatrix on a given historical date. On October 10, 2024 Pulmatrix was worth 2.17 at the beginning of the trading date compared to the closed value of 2.15. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pulmatrix stock. Still, in general, we apply an absolute valuation method to find Pulmatrix's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pulmatrix where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pulmatrix's related companies.
| Open | High | Low | Close | Volume | |
| 2.07 | 2.18 | 2.07 | 2.14 | 8,889 | |
10/10/2024 | 2.17 | 2.17 | 2.04 | 2.15 | 9,185 |
| 2.11 | 2.14 | 2.07 | 2.12 | 3,849 |
| Backtest Pulmatrix | | | Pulmatrix History | | | Pulmatrix Valuation | Previous | Next |
Pulmatrix Trading Date Momentum on October 10, 2024
| On October 11 2024 Pulmatrix was traded for 2.12 at the closing time. The top price for the day was 2.14 and the lowest listed price was 2.07 . The trading volume for the day was 3.8 K. The trading history from October 11, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.40% . The trading delta at closing time against the current closing price is 6.05% . |
Pulmatrix Fundamentals Correlations and Trends
By evaluating Pulmatrix's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pulmatrix's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pulmatrix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pulmatrix Stock history
Pulmatrix investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pulmatrix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pulmatrix will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pulmatrix stock prices may prove useful in developing a viable investing in Pulmatrix
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts. Pulmatrix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.
Pulmatrix Stock Technical Analysis
Pulmatrix technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pulmatrix Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Pulmatrix cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pulmatrix November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Pulmatrix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pulmatrix shares will generate the highest return on investment. By undertsting and applying Pulmatrix stock market strength indicators, traders can identify Pulmatrix entry and exit signals to maximize returns
Pulmatrix Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pulmatrix's price direction in advance. Along with the technical and fundamental analysis of Pulmatrix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pulmatrix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1583 | |||
| Jensen Alpha | 2.33 | |||
| Total Risk Alpha | 0.4219 | |||
| Sortino Ratio | 0.4678 | |||
| Treynor Ratio | (4.91) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.